Chromium picolinate therapy in pre/diabetes care: recognition of individual risks and outcomes
详细信息 查看全文
- 作者：Olga Golubnitschaja (160)
Kristina Yeghiazaryan (160)
Hans H Schild (160) - 刊名：The EPMA Journal
- 出版年：2014
- 出版时间：February 2014
- 年：2014
- 卷：5
- 期：1-supp
- 全文大小：580 KB
- 参考文献：1. Yeghiazaryan K, Schild HH, Golubnitschaja O: Recognition of individual risks by analysis of subcellular imaging insights into chromium picolinate therapy in pre/diabetes care, search into its safety and opinion controversy. In / New Strategies to Advance Pre/Diabetes Care: Integrative Approach by PPPM in Diabetes Edited by Mozaffari M; Book-Series 鈥淎dvances in Predicitive, Preventive and Personalised Medicine鈥?/em>. Springer; 2013.
2. Golubnitschaja O, Yeghiazaryan K: Opinion controversy to chromium picolinate therapy鈥檚 safety and efficacy: ignoring 鈥榓necdotes鈥?of case reports or recognising ndividual risks and new guidelines urgency to introduce innovation by predictive diagnostics? / EPMA J 2012, 3:11. CrossRef
3. Yeghiazaryan K, Cebioglu M, Golubnitschaja O: Global Figures Argue in Favour of Preventive Measures and Personalised Treatment to Optimise Inadequate Diabetes Care. In / New Strategies to Advance Pre/Diabetes Care: Integrative Approach by PPPM. Edited by: Mozaffari M. Springer; 2013.
4. Golubnitschaja O, Costigliola V: Common origin but individual outcomes: time for new guidelines in personalized healthcare. / Personalized Med 2010, 7:561鈥?68. CrossRef
5. Yeghiazaryan K, Peeva V, Shenoy A, Schild HH, Golubnitschaja O: Chromium-picolinate therapy in diabetes care: molecular and subcellular profiling revealed a necessity for individual outcome prediction, personalised treatment algorithms and new guidelines. / Infect Disord Drug Targets 2011, 11:188鈥?95. CrossRef - 作者单位：Olga Golubnitschaja (160)
Kristina Yeghiazaryan (160)
Hans H Schild (160)
160. Radiologic Clinic, University of Bonn, Kragujevac, Germany - ISSN：1878-5085
文摘